Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs fentanyl with propofol for painless abortion sedation
ChiCTR2500097499Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in None (4 arms), sponsored by Dazhou Central Hospital. Primary endpoints: Mean arterial pressure and Heart rate. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
oliceridine
Beyond the preview
Go deeper on ChiCTR2500097499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097499.